SCHEMBL6920987

SCHEMBL6920987

COC(Oc1cccc([N+](=O)[O-])c1)C(=O)N(C1CCCCC1)C1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CHRNB4 P30926 1/20 0.42
CHRNA3 P32297 1/20 0.42
MGLL Q99685 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
POLB P06746 2/20 0.40
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
GAA P10253 1/20 0.40
EPHX1 P07099 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6920389 0.81 ALDH1A1 (0.39) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL6921768 0.77 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AMAPTCHRNB2
SCHEMBL6928014 0.76 ALDH1A1 (0.49) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL27479893 0.70 POLB (0.63) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL15054178 0.69 SLC6A2 (0.66) ALDH1A1MEN1KMT2ACHRNB4CHRNA3
SCHEMBL16097479 0.69 LMNA (0.48) ALDH1A1MEN1KMT2AMAPTCHRNB2
SCHEMBL31518364 0.69 SLC6A2 (0.66) ALDH1A1MEN1KMT2ACHRNB4CHRNA3
SCHEMBL20299326 0.68 TSHR (0.52) ALDH1A1CHRNB2CHRNA4
SCHEMBL8316951 0.68 POLB (0.57) ALDH1A1MEN1KMT2ACHRNB4CHRNA3
SCHEMBL27612334 0.68 CHRNB2 (0.51) ALDH1A1MEN1KMT2ARAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001766-B1 COMPOUNDS FOR THE TREATMENT OF CCR5-MEDIATED DISEASES SMITHKLINE BEECHAM CORP (US) 2003-04-09 EP disclosed
US-6515027-B1 Ligands, agonists or antagonists, of the CC chemokine receptor CC-CKR5 SMITHKLINE BEECHAM CORP. 2003-02-04 US disclosed
EP-1001766-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2001-04-04 EP disclosed
EP-1001766-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2000-05-24 EP disclosed
WO-1999001127-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 1999-01-14 WO disclosed